Investigators who conducted 2 clinical trials concluded that focal therapy is not inferior to radical prostatectomy with respect to treatment failure. Focal therapy such as high-intensity focused ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced the completion of patient enrollment in SUNRISE-I, a randomized controlled trial evaluating the safety and ...

EDAP TMS SA announced the positive results of its Focal Ablation Versus Radical Prostatectomy (FARP) Study at the AUA Annual Meeting on April 27, 2025. The trial achieved its primary goal, ...

Key Points Interested in Edap Tms S.A.? Here are five stocks we like better. Edap Tms is rebranding as FocalTherics and ...

View EDAP TMS SA Sponsored ADR EDAP stock quote prices, financial information, real-time forecasts, and company news from CNN.